Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Dementia, a degenerative disease affecting millions globally, is projected to triple by 2050. Early and precise diagnosis is essential for effective treatment and improved quality of life. However, current diagnostic approaches often show inconsistent performance across multi-racial and multi-ethnic groups, raising concerns about fairness and clinical reliability. This study investigates performan...
Alzheimer's disease (AD) is a highly heritable neurodegenerative disorder whose genetic architecture remains incompletely understood, particularly with respect to rare variants and higher-order interactions. We applied Individualized Bayesian Inference-Decision Tree (IBI-DT) to 790,000 whole-exome sequencing variants from 8,292 unrelated White British individuals in the UK Biobank, using genome-wi...
BACKGROUND: Cognitive impairment is the growing challenge that requires early diagnosis and personalized management of neurodegenerative conditions li...
Depressive disorder (DD), Alzheimer's disease (AD), and schizophrenia (SZ) are evolutionarily relevant traits that disrupt neural networks supporting ...
Convolutional neural networks (CNNs) achieve high performance in electroencephalographic (EEG) classification tasks; however, their decision-making me...
BACKGROUND: Identifying older home care recipients at risk of institutionalization in advance is crucial for providing preventive services. Supporting...
There is a shortage of physicians trained in the specialized care of Alzheimer's disease (AD). One possible solution is to use machine learning (ML)/a...
PURPOSE: Assessing generalizability and performance of machine learning models in clinical settings is crucial. In this study, we aimed to test our mo...
BACKGROUND: The global prevalence of dementia continues to rise and demands scalable, nonpharmacological interventions. Digital cognitive training has...
Accelerated brain aging is increasingly recognized as a transdiagnostic risk factor for neuropsychiatric and neurodegenerative disorders, yet its meta...
OBJECTIVES: To systematically investigate the molecular associations between 6PPD-quinone (6PPD-Q), an environmental transformation product of the tir...
Early detection of dementia is critical for timely intervention and disease management, yet it remains a challenging task due to the fragmented nature...
BACKGROUND AND OBJECTIVES: Outer nuclear layer (ONL) thinning has been identified in frontotemporal lobar degeneration (FTLD); however, its utility fo...
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease found in individuals with a history of repetitive head injury (RHI) ...
BACKGROUND: Alzheimer disease (AD) is characterized by progressive cognitive decline, with olfactory dysfunction emerging among its earliest symptoms....
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia globally. Early prediction, prior to the onset ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that severely affects memory, cognition, and behavioral functions, making early a...
OBJECTIVES: Social determinants of health (SDOH) may improve Alzheimer's disease (AD) risk prediction by capturing upstream contextual risk beyond rou...
Identifying individuals at risk of Alzheimer's disease (AD), particularly in the preclinical and early stages, remains challenging. Although deep lear...
Addressing the computational efficiency and cross-device generalization challenges faced by acoustic scene classification in resource-constrained envi...